About Medulloblastoma

October 25, 2016 | Video

Medulloblastoma is the most common malignant primary brain tumor in children. Standard of care treatment consists of surgical removal of the tumor followed by chemotherapy and radiation, depending on the patient’s staging and age. Radiation therapy is rarely administered to children under three years of age because of the high potential for serious neurodevelopmental deficits, further limiting the treatment options available to the youngest patients. While modern treatments have led to improvements in survival, the risk of recurrence as well as the long-term side effects associated with surgery, radiation, and chemotherapy underscore the urgent need for new therapeutic approaches.

View More Videos

  • VBI-1901: Phase 2a Data & Clinical Update in Recurrent GBM

    Discussion of Data Presented at Society for Neuro-Oncology (SNO) 2020 Annual Meeting

    Date: November 19, 2020
    Presenters: Jeff Baxter, VBI CEO, and Dr. David E. Anderson, Ph.D., VBI CSO

    Watch NowArrow
  • VBI-1901: AACR Data and Clinical Update in Recurrent GBM

    Discussion of Data Presented at 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II

    Date: June 22, 2020
    Presenters: Dr. Allen Waziri, M.D., and Dr. David E. Anderson, VBI CSO

    Watch NowArrow
  • Overview of First- and Second-Generation Hepatitis B Vaccines

    Date: October 27, 2016
    Presenters: Dr. Daniel Shouval, M.D., and Dr. Florian Schödel, M.D.

    Watch NowArrow
  • Overview of the Design of VBI-1901, VBI’s Therapeutic Cancer Vaccine Candidate

    Date: October 26, 2016
    Presenters: Dr. David E. Anderson, VBI CSO

    Watch NowArrow
  • Preclinical Data from VBI-1901, VBI’s Therapeutic Cancer Vaccine Candidate

    Date: October 25, 2016
    Presenters: Dr. David E. Anderson, VBI CSO

    Watch NowArrow
  • About Glioblastoma (GBM)

    Date: October 25, 2016
    Presenters: Dr. David E. Anderson, VBI CSO

    Watch NowArrow
  • About Hepatitis B (HBV)

    Date: October 15, 2016
    Presenters: Dr. Daniel Shouval, M.D., and Dr. Florian Schödel, M.D.

    Watch NowArrow
  • Overview of VBI-1501, VBI’s Cytomegalovirus (CMV) Vaccine Candidate

    Date: August 15, 2014
    Presenters: Dr. David E. Anderson, VBI CSO

    Watch NowArrow
  • Overview of VBI’s Enveloped Virus-Like Particle (eVLP) Platform Technology

    Date: August 5, 2014
    Presenters: Dr. David E. Anderson, VBI CSO

    Watch NowArrow

Sign-up for Our Distribution List to Receive the Latest News and Updates from VBI

Sign Up NowArrow
Go top